Results for medical translation from Norwegian to English

medical home
home, medical

medical record administrators
medical record administrator

medical assistance, title 19
med assistance title 19

unified medical language system
unified medical language system

alliance medical molecular imaging ltd., storbritannia
alliance medical molecular imaging ltd., uk

free online medical dictionary engilsh to farsi
free online medical dictionary to engilsh farsi

national institute of general medical sciences, usa
national institute of general medical sciences

biotest medical, s.l.u. c/ frederic mompou,
biotest medical, s.l.u. c/frederic mompou,

terminologien er basert på meddra (medical dictionary for reggulatory activities).
adverse reaction terminology is based upon the medical dictionary for regulatory activities (meddra)

plasma fractionation institute (pfi), mda services centre sheba medical centre
plasma fractionation institute (omrix-pfi), mda services center sheba medical center

rekombinante hematopoetiske vekstfaktorer kan brukes i overensstemmelse med institusjonelle retningslinjer eller retningslinjer fra european society for medical oncology (esmo).
recombinant hematopoietic growth factors may be used according to institutional or european society for medical oncology (esmo) guidelines.

for hvert organ eller hver organgruppe er de opptatte dosene beregnet med en metodikk som er utviklet av mird (medical internal radiation dose).
for each organ, or group of organs, the absorbed doses have been calculated using the methodology developed by the mird (medical internal radiation dose).

dosimetriestimatene er basert på kliniske biodistribusjonsstudier ved hjelp av metoder utviklet for stråledoseberegninger av mird (medical internal radiation dose) committee of the society of nuclear medicine.
the dosimetry estimates were based on clinical biodistribution studies using methods developed for radiation dose calculations by the medical internal radiation dose (mird) committee of the society of nuclear medicine.

alle pasienter måtte ha hatt en forhistorie med røyking på minst 10 pakkeår; en post-salbutamol fev1/fvc ratio på mindre enn eller lik 0,70; post-salbutamol fev1 mindre enn eller lik 70 % av forventet verdi, og de måtte ha en ”modified medical research council” (mmrc) dyspné verdi 2 (skala 0-4) ved screening.
all patients were required to have a smoking history of at least 10 pack years; a post-salbutamol fev1/fvc ratio less than or equal to 0.70; post-salbutamol fev1 less than or equal to 70% predicted and have a modified medical research council (mmrc) dyspnea score 2 (scale 0-4) at screening.